Page last updated: 2024-12-06
acid black 24
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 18307 |
| SCHEMBL ID | 591337 |
| MeSH ID | M0504370 |
Synonyms (93)
| Synonym |
|---|
| 1-naphthalenesulfonic acid, 8-(phenylamino)-5-[[4-[(5-sulfo-1-naphthalenyl)azo]-1-naphthalenyl]azo]-, disodium salt |
| acid leather black 3b |
| coomassie fast black b |
| sulfonine black b |
| alphanol black gv |
| azo cyanine black bb |
| yamada acid fast black 8bx |
| pontacyl fast black bbo |
| durol black 2b |
| acid black 24 |
| optanol cyanine black bb |
| milling black bb |
| milling fast black 2b |
| tertracid fast black cb |
| cirene black bra |
| suminol milling black 8bx |
| alphanol black bbn |
| telon fast black s |
| xylene milling black 3bs |
| naphthazine sulphon black bc |
| supranol fast black bb |
| sulphon cyanine black ba-cf |
| fast acid black 2a |
| acid fast black 2a |
| sulphonine fast black grv |
| colacid fast black 2a |
| optanol cyanine black b |
| eniacid cloth black br |
| sulfon black s |
| sulphone black bb |
| supranol fast black b |
| durol black ba |
| eriosin fast black 2b |
| shikiso acid fast black 8bx |
| amacid milling black dn |
| sulphonol black br |
| benzyl fast black 3b |
| cyanine fast black 2b |
| naphthazine sulphon black d |
| sulphonol black b |
| tertracid fast black 2b |
| sulphon cyanine black dn |
| azo cyanine black b |
| fast acid black 2b |
| cloth black mb |
| durol black b |
| java milling black b |
| suminol black 8bx |
| acilan fast black 3bn |
| bucacid black 2b |
| benzyl fast black b |
| hispacid fast black 2b |
| benzyl fast black cib |
| neutral black 3b |
| pontacyl fast black bbn |
| eriosin fast black b |
| amacid milling black sg |
| vondamol fast black b |
| folan fast black b |
| amacid milling black sb |
| c.i. acid black 24, disodium salt |
| fast black b |
| acid fast black 8bx |
| sulphonine fast black rb |
| cyanine fast black 2bg |
| sulfonine black bb |
| fenazo black sb |
| neutral sulphonyl navy n |
| amacid milling black s 2b |
| aminyl black f 8bl |
| midlon black p 2b |
| acid fast black 8b |
| nsc 47765 |
| disodium 8-(phenylamino)-5-((4-((5-sulphonatonaphthyl)azo)naphthyl)azo)naphthalenesulphonate |
| einecs 221-343-4 |
| nsc 7830 |
| 1-naphthalenesulfonic acid, 8-(phenylamino)-5-((4-((5-sulfo-1-naphthalenyl)azo)-1-naphthalenyl)azo)-, disodium salt |
| ext d and c black no.1 |
| 3071-73-6 |
| c.i. 26370 |
| 1-naphthalenesulfonic acid, 8-(phenylamino)-5-(2-(4-(2-(5-sulfo-1-naphthalenyl)diazenyl)-1-naphthalenyl)diazenyl)-, sodium salt (1:2) |
| SCHEMBL591337 |
| AKOS025310857 |
| J-018081 |
| acid black 24 (c.i. 26370) |
| mfcd00004129 |
| OLPWJTQWWFWEFS-UHFFFAOYSA-L |
| acidblack24 |
| disodium;8-anilino-5-[[4-[(5-sulfonatonaphthalen-1-yl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1-sulfonate |
| 1-naphthalenesulfonic acid, 8-(phenylamino)-5-[2-[4-[2-(5-sulfo-1-naphthalenyl)diazenyl]-1-naphthalenyl]diazenyl]-, sodium salt (1:2) |
| DTXSID10889368 |
| STARBLD0009516 |
| disodium 8-(phenylamino)-5-[[4-[(5-sulphonatonaphthyl)azo]naphthyl]azo]naphthalenesulfonate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 21.80
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.80) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||